Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study (Q38496208)
Jump to navigation
Jump to search
scientific article published on 03 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study |
scientific article published on 03 January 2011 |
Statements
1 reference
Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study (English)
1 reference
Henry Krum
1 reference
Doron Aronson
1 reference
Joseph G Verbalis
1 reference
Matthias Mueller
1 reference
DILIPO investigators
1 reference
3 January 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference